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Renal acid—base metabolism after ischemia. The response of the
kidney to ischemia—induced cellular acidosis was followed over the
immediate one hr post—ischemia reflow period. Clearance and extrac-
tion experiments as well as measurement of cortical intracellular pH
(pH1) were performed on mactin—anesthetized Sprague—Dawley rats.
Arteriovenous concentration differences and para-aminohippurate ex-
traction were obtained by cannulating the left renal vein. Base produc-
tion was monitored as bicarbonate released into the renal vein and
urine; net base production was related to the renal handling of
glutamine and ammonia as well as to renal oxygen consumption and
pH,. After a 15 mm control period, the left renal artery was snared for
one—half hr followed by release and four consecutive 15 mm reflow
periods. During the control period, cortical cell pH, measured by
['4C]-5,5-Dimethyl-2,4-Oxazolidinedione distribution was 7.07 0.08,
and Q-02 was 14.1 2.2 micromoles/min; neither net glutamine
utilization nor net bicarbonate generation occurred. After 30 mm of
ischemia, renal tissue pH fell to 6.6 0.15. However, within 45mm of
reflow, cortical cell pH returned and exceeded the control value, 7.33
0.06 vs. 7.15 0.08. This increase in pH1 was associated with a
significant rise in cellular metabolic rate, Q-02 increased to 20.3 6.4
micromoles/min. Corresponding with cellular alkalosis was a net pro-
duction of bicarbonate and a net ammonia uptake and glutamine
release; urinary acidification was abolished. These results are consist-
ent with a nonexcretory renal metabolic base generating mechanism
governing cellular acid base homeostasis following ischemia.
Renal ischemia results in profound changes in cellular
acid—base homeostasis, resulting from an increase in endoge-
nous acid production. Estimates of renal cellular pH using glass
electrodes [I] or NMR [2] reveal a pH, of 6.6 or less following
relatively mild ischemia. The post-ischemia response of tubular
cells to this acute acidosis has not, however, been studied. In
systemic metabolic acidosis, the ['4C]-5,5-Dimethyl-2,4-
Oxazolidinedione (DM0) estimated cortical cell pH falls from
6.99 0.02 to 6.83 0.02 [3], while the renal response is to
generate bicarbonate from extraction of glutamine and conver-
sion of its amide and amino nitrogen to ammonia and its carbon
skeleton to neutral products [4, 5]. In response to systemic
metabolic acidosis, base generation and cellular acid base
homeostasis are dependent upon urinary excretion of titratable
acid and ammonium. However, there may also exist a
nonexcretory metabolic mechanism for generating bicarbonate
dependent upon substrate interconversion and product forma-
tion [6]; evidence for this has been obtained in cortical slice
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preparations [6, 7]. The purpose of this study was to delineate
the renal response to isehemia—induced cellular acidosis over
the early recovery period of one hour of reflow [8]. Renal
handling of bicarbonate, ammonia, and glutamine was studied
by clearance and extraction techniques to determine the rela-
tionship of these substances to cellular acid base balance and
metabolism during recovery. The results to follow suggest that
ischemia—induced celluar acidosis reverses to alkalosis associ-
ated with net bicarbonate release; base generation was associ-
ated with net glutamine release and an inability to acidify the
urine. Therefore, these results are consistent with a nonex-
cretory base generation mechanism dependent upon renal
metabolism.
Methods
Experiments were performed on in vivo functioning kidneys
of male Sprague—Dawley rats weighing between 400 and 450
grams. The animals were anesthetized with mactin, 100 mg
kg administered intraperitoneally and placed on an animal
warming board in order to maintain body temperature between
36 and 38°C. After tracheostomy, the femoral artery and vein
were cannulated followed by an intravenous prime consisting of
0.5 pCi of [methoxy3-H]-inulin and 1.0 pCi of p-[glycyl-l-'4C]-
amminohippurate (New England Nuclear, Boston, Massachu-
setts, USA). Following the injection of the prime, a mainte-
nance infusion of 0.14 M NaCI containing tracer amounts of
labelled inulin and PAH was administered at a rate of 0.017
mliter per minute per 100 g of rat wt (delivering 0.01 pCi per
minute per 100 g body wt of inulin and PAH). The left ureter
was then cannulated with PE 30 tubing via a small midline
incision, after which an Intracath 22 GA heparinized catheter
was inserted into the left testicular vein and on into the left renal
vein. When the testicular vein drained directly into the inferior
vena cava, a specially designed catheter bearing a 24 gauge
needle was implanted directly into the renal vein near the hilus,
and the needle was anchored in place using a cyanoacrylate
adhesive (Loctite Corporation, Cleveland, Ohio, USA).
Forty—five minutes were allowed for equilibration after which a
control 15 mm urine collection was obtained in a tared vessel
under oil; arterial and renal venous blood samples were drawn
over a one mm period at the midpoint. Complete occlusion of
the left renal artery was then accomplished with a minimum of
trauma by looping the vessel with a ligature and kinking it into
a snug—fitting polyethylene tube. Urine formation promptly
halted as the kidney blanched and then turned a dark purple hue
within several minutes. After 30 mm, the snare was released,
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turning the kidney a bright red, and four consecutive 15 mm
post-ischemic periods were observed. The duration of the entire
experiment was 135 mm.
Blood, plasma, and urine analysis
Blood samples were anaerobically drawn and capped in
heparinized, greased glass syringes for immediate blood pH,
oxygen, and ammonia determinations. The remaining plasma
sample was then analyzed for total CO2 [91. Oxygen content
was determined using a fuel cell analyzer (Lex-02-Con,
Lexington Instruments Corp., Waltham, Massachusetts, USA)
calibrated against room air. Blood and urine ammonia concen-
trations were measured using a modification of the microdiffu-
sion technique [10]. Bicarbonate concentration was obtained
from pH and total CO2 measurements according to the
equation:
[HC03] = [C02] total/(l + l/l0" — PI(a)
A pKa of 6.10 was used. Urine samples were weighed (0.0001
g), the pH was determined, and the ammonia and total CO2
were analyzed as above. Urine and plasma aliquots were
monitored for radioactivity by liquid scintillation spectrometry
with quenching control provided by channel ratio analysis
(Beckman LS 8000, Beckman Instruments, Fullerton, Califor-
nia, USA). Plasma and urine glutamine and glutamate concen-
trations were analyzed by enzymatic analysis [11] coupled to
the fluorimetric monitoring of nicotinamide adenine dinucleo-
tide reduction [12].
Estimation of renal cortex intracellular pH
Intracellular pH, estimated by the distribution of ['4C]-5,5-
Dimethyl-2,4-Oxazolodinedione (New England Nuclear) [13,
14], was determined in the control right kidney and post-
ischemic left kidney 45 mm after releasing the arterial snare.
The cortical slice technique 1141 was modified to correct for an
increase in cellular Na content occurring after ischemia [15],
which has the effect of increasing the 22Na space and, there-
fore, yielding spuriously high extracellular volume value. Thus:
Ve(cOlTected) = Ve(22N*) X F
where F = I — [(NaL — Nar)/Naj]; V = extracellular
space, Na = Na content in mM/kg kidney, r = right control
renal cortical Na content, 41.7 1.2, and L left post-
ischemic renal cortical Na content, 54.9 2.8. No other
corrections were applied. Intracellular pH1 was estimated from
[91;
pH1 = pK' + log[(Ct/Ce) (I + V/V1) — V/V1)
x [(l0(PPK) + 1) — 1]
where Ct and Ce are isotopic DM0 concentrations in tissue and
plasma, respectively, and Y and V1 are the extracellular and
intracellular space values; the pKa of DM0 was taken to be
6.13 [131. Briefly, the procedure for estimating cortical cell pH
was as follows: After releasing the arterial snare, a prime
injection of 2 Ci 22Na and 10 Ci ['4C]-DMO was adminis-
tered i.v. followed by a maintenance infusion of ['4C]-DMO for
45 mm at which time 200 mg slices were promptly removed
from right and left kidney cortices. Wet wt determination,
quantitation of 22Na activity, and homogenization were per-
formed as described [141. After neutralization, 0.2 muter ali-
quots of the supernatant were placed on a prepared AG 50W-X8
column, 0.7 x 4 cm (BioRad, Richmond, Ca) and eluted with
water [14] into counting vials; the column quantitatively re-
tained 22Na with approximately 4% of the 22Na being eluted
and contributing to the radioactivity detected in the '4C chan-
nel. '4C radioactivity was monitored by liquid scintillation
spectrometry in a dual channel mode (Beckman LS 8000) using
channel ratios for quench control.
Renal ATP andpH analysis
Kidneys were removed prior to, during, and 45 mm following
ischemia, employing the above protocol. For ATP analysis,
kidneys were quickly thrown into a Waring blender containing
ice cold 10% trichloroacetic acid (TCA) and promptly homog-
enized. The TCA homogenate, a 1:10 (wt:vol) dilution, was
centrifuged and aliquots of the supernatant extracted with ether
and the pH adjusted to 5.0. Aliquots were then analyzed for
ATP by high performance liquid chromatography; identification
of the eluted peaks was made by spiking samples with known
standards. For tissue pH, kidneys were quickly removed,
weighed and homogenized under oil in 10 muter of ice cold 0.25
M mannitol. The homogenate was then centrifuged, as above,
and the pH of the resulting homogenate was determined using a
Corning model 7 pH meter; total CO2 was immediately mea-
sured using a Natelson microgasometer 191. This procedure
allowed the determination of pH and CO2 in less than 15 mm;
homogenates kept on ice over that time period did not show any
significant alterations in either parameter.
Calculations
Glomerular filtration rate (GFR) was estimated from the
inulin clearance, while renal plasma flow (RPF) was calculated
from PAH clearance divided by fractional PAH extraction.
Filtered HCO3 load was determined from the product of the
GFR and the HCO3 concentration; fractional excretion, FE,
was calculated from excreted HCO3 divided by filtered HCO3.
Renal venous HCO3 release was quantitated from RPF, cor-
rected for urine flow [16], multiplied by the arteriovenous HCO3
concentration difference. Net HCO3 production was calculated
as the sum of excreted plus renal venous HCO3 released. For
glutamine, the amount filtered, the FE, the amount released,
and the net balance were all calculated as they were for HCO3
and ammonia. Renal oxygen consumption was calculated from
the arteriovenous blood oxygen content times the renal blood
flow, RPF times the hematocrit factor. The data analysis was
performed using the Student—Newman—Keuls' test after analy-
sis of variance provided rejection of the nul hypothesis at the P
<0.05 level.
Results
Table 1 presents HCO handling by the post-ischemic kidney.
In the initial 15 mm reflow period, absolute HCO3 excretion
increased from the control value of 43 5 nmole/min to 910
45 nmole/min despite a filtered HCO3 load only one third of the
control value. In the second period, both the absolute excretion
rate and FE of HCO3 greatly increased; UV-HCO3 was 62 times
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Table 1. Bicarbonate handling by the post-ischemic kidney






Control 1,803a 188 23.9 1.1 43,000 5,000 43 5 0.1 0.1 5.1 5.0 5.0 5.0
(7) (5) (5)
Ischemia reflow, mm
0—15 633 196b 22.1 1.7 14,000 2,000" 910 45" 6.5 1.8" —3.2 2.9 —4.4 3.2"
(7) (5) (5)
15—30 997 327k' 22.5 1.9 22,000 2,000" 2,684 l34" 12.2 1.7 —4.1 0.7 —5.9 0.9"
(7) (5) (5)
30—45 868 278" 21.9 2.1 19,000 2,000" 2,242 112b.c 11.8 17b.c —6.8 2.5 —8.7 24b
(7) (5) (5)
45—60 781 307" 20.5 1.2" 16,000 2,000b 1,088 196" 6.8 1.1" —2.8 1.2 —4.1 2.9"
(7) (5) (5)
Minus sign indicates release of clamping.
a Mean SEM with number in parenthesis indicates number of rats per group.
"Significantly different from control, P < 0.05.
Significantly different from 0—15 minute period.
Table 2. Ammonia handling by the post-ischemic kidney
Q pH UV-NH4 UV-NH4/GFR Uptake Net
piiter/min Units nmole/min nmole/mliter nmole/min
Control l0 4 6.1 0.3 407 89 209 46 —745 270 —1,152 424
Ischemia reflow, mm
0—15 40 13" 7.2 01b 231 53" 340 78" —504 179 —735 283
15—30 100 29" 7.6 2" 102 19b, 105 18b.c —157 75Ic —259 92b.c
30—45 92 22b 75 01b 89 21b,c 102 33b,c 759 112"" 670
45—60 66 28 7.4 0.2" 172 33b 220 42 —460 82b —632 60
Minus sign indicates release.
a Means SEM from 5 to 7 rats.
b Significantly different from control, P < 0.05.
Significantly different from 0—15 mm reflow period.
the control value, 2, 684 134 vs. 43 5 nmole/min. Urinary
HCO3 concentration increased from 4.3 0.4 to 26.8 1.9 mM
after 15 to 30 mm of reflow. The bicarbonaturia was maintained
in the subsequent period, but declined in the final period.
Bicarbonate was released into the renal vein at a statistically
significant rate of 6.8 2.5 mole/min at 30 to 45 mm of reflow;
other periods failed to achieve significance. On the other hand,
net bicarbonate release, the sum of UV-HCO3 and renal venous
release, was significant over all four reflow periods. Renal
ammonia handling by the post-ischemic kidney is shown in
Table 2. UV-NH4 was significantly reduced in all four reflow
periods while urine pH and urine flow both increased, peaked,
and then decreased with reflow. The rise in urine pH corre-
sponded with the bicarbonaturia shown in Table 1.
UV= NH4IGFR was significantly increased at 0 to 15 mm of
reflow, then reversed to being significantly decreased in the two
ensuing periods. Ammonia release into the renal vein repre-
sented 64% of the net ammonia release in the control period.
After ischemia, however, release into the renal vein was
initially maintained but then decreased to only 19% of control at
15 to 30 mm. At 30 to 45 mm, ammonia release actually reverted
to an uptake, 759 112 nmole/min; this was also associated
with the lowest absolute, UV-NH4. In the final period, renal
venous uptake ceased and returned to a large release, 460 824
nmole/min. Net ammonia production, UV-NH4 plus renal
venous release, reflected this pattern with production being
markedly reduced in the second period and reverting to actual
uptake in the third period. Ammonia production returned
toward control values during the fourth period.
Table 3 shows renal glutamine handling in the postischemic
period. UV-Gln rates were depressed to zero in the first reflow
period, then dramatically increased in the three subsequent
periods; FE of glutamine rose to 58—fold greater than control at
30 to 45 mm. Net glutamine uptake was not significantly
different from zero in the control period [12, 17]. With reflow,
glutamine uptake initially appeared, then reversed to produc-
tion rate of 630 225 nmole/min in the third reflow period. In
the final period, glutamine production ceased and returned to a
large net uptake of 1,001 282 nmole/min, only a fraction of
which represented UV-Gln (38 7 nmole/min).
These relationships are illustrated in Figures 1 and 2. Figure
1 depicts release into the urine of HCO3 -,NH4,GIn, and Glu.
With reflow, UV-NH4 initially fell, but not when expressed on
the basis of GFR (Table 2), presumably reflecting in part
intraluminal conversion of filtered Gln to Glu. Gln excretion
decreased (as Glu excretion rose), then rose with a large
UV-Glu at 15 to 30 mm of reflow. Subsequently, UV-GLN was
disproportionately higher than UV-Glu at 30 to 60 mm. Bicar-
bonate excretion and UV-NH4 were inversely related during
the one hr reflow period. Renal venous release of bicarbonate
also showed an inverse relationship with ammonia release (Fig.
2). Renal glutamine release into the renal vein paralleled the
release of bicarbonate over the 30 to 45 mm reflow period and
was directly and stoichiometrically related to ammonia uptake.
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Control l,803 188 416 55 749 210 2.4 1.2 0.3 0.2 7.6 120 9 16.2
lschemia reflow, miii
0—15 633 192b 376 40 237 5b 0 0 150 61b 150 61
15—30 977 327b 438 70 429 l20' 52 6b 12.1 24b.c I 24C 51 36
30—45 868 278b 400 20 344 110h 60 5b 17.4 33b,c —570
180 —630225
45—60 781 307b 483 25 377 l50 38 75 10.1 1,5b.c 1,049 295I,C 1,011 282
Minus sign indicates release.
a Means SEM from four rats.
b Significantly different from control, P < 0.05.
Significantly different from first reflow period.
FIg. 1. Effect of 30 mm of ischemia on urinaly excretion of bicarbonate,
ammonia, glutamine, and glutamate. Control period studied 15 mm
prior to left renal artery occlusion with periods, I, 2, 3 and 4 re-
presenting consecutive IS mm periods after initiation of reflow. Results
are means from 4 to 7 animals with SEM appearing in tables I, 2, and
3 respectively. Symbols are (in nmole min'): Ammonia (x—x);(•—•) bicarbonate; GIn (O—O; and Glu (O—O).
Extracellular and intracellular acid base parameters, Q-02,
and ATP content before and after ischemia are shown in Table
4. Blood pH remained constant during the post-ischemic reflow
period while pCO2, compensating for a slight decrease in
plasma HCO3 concentration, was significantly reduced. Corti-
cal cell pH, from the control kidneys, 7.08 0.07, was slightly
higher, although not significantly greater than that previously
reported using the DM0 method, 6.97 0.03 1141, and was
close to that observed in tissue homogenates, pH, 7.08 0.05.
Ischemia alone reduced tissue pH (pH1) to 6.60, a value in good
agreement with other studies [1, 21, while at 30 mm of reflow,
pH1 rose to 7.30 0,15, indicating a relative tissue alkalosis.
Cellular alkalosis at 45 mm of reflow was also apparent using
Control Reflow periods
Fig. 2. Effect of3O mm of ischemia on renal venous release of bicarbonate,
ammonia and glutamine before and after 30 mm of ischemia. Symbols are
(in nmoles/min): ammonia (x—x); Gin (O—O); (in mo1e/min')
bicarbonate (•—•).
the DM0 method; pH, of the left post-ischemic kidney rose to
7.33 0.06, a value significantly greater than the nonischemic
right kidney, pH1 = 7.15 0.08. The slight, but not significant
increase in pH, of the right kidney as compared to the control
kidney may reflect the reduction in systemic pCO2 at that time,
an effect that may increase pH1 [13]. Renal cortical water
content was significantly increased after 45 mm of reflow,
reflecting an increase in cellular water content, V1 = 420 40
piiter/g as compared to V1 = 320 20 diter/g in control. Renal
ATP content was decreased from 1,710 80 to 181 32
nmole/g after 30 mm of ischemia; it then returned to 849 108
nmole/g, 50% of control after 45 mm of reflow, in agreement
with previous reports [181. Renal Q-0,, 14.1 2.9 .tmole/min,
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Table 4. Extra and intracellular acid—base balance and metabolism after ischemia
Control Ischemia
Post ischemia, 45 mm
Right Left
Extracellular
pHe, U(6) 7.41 .0l 7.42 0.02 7.42 0.02 7.42 0.02
HC03, M 24.1 0.9 22.4 1.8 21.6 1.0 21.6 1.0
(6)
pCO2, mm Hg
(6) 39.0 1.0 38.0 2.0 29.0 3.0" 29.0 30b


































pH,, U 7.08 0.05 6.60 0.15 — 7.30 IS"






Q-02, ismole/min 14.1 2.9
(7)
— — 20.3 6.4"
(4)
a Mean SEM from number of kidneys in parentheses.
"Significantly different from control P < 0.05.
Significantly different from right kidney, P < 0.05.
was significantly increased to 20.3 6.4 imole/min after 45
mm of reflow.
Discussion
Our aim was to delineate the renal response to cellular
acidosis induced by 30 mm of ischemia. There is little doubt that
this duration of ischemia resulted in profound cellular acidosis;
tissue pH determined by glass electrode [1] and NMR [2] give
values similar to that observed in the present study, 6.6 (Table
4). Acid generated under these conditions derives from
anaerobic metabolism as well as cellular catabolism [18, 19].
For example, the lactic acid content of rat kidney rises 500%
after 30 mm of ischemia [18], while acid—generating ATP
hydrolysis to ADP reduces the former to 10% of control [18,
Table 4]. With reflow, estimated cellular pH returns to and then
exceeds the control value after 45 mm (Table 4). It is important
to point out that these values, however, are estimates of a broad
average of values for cellular pH encompassing a heterogenous
intracellular milieu. Thus we do not employ these values as an
accurate value of cellular pH1, but rather, as pointed out [3, 13,
14], they do suggest the direction of change as well as the
relative magnitude of that change. Furthermore, our experi-
mental design allows a comparison of the post-ischemic change
in comparing the right control with the left post-ischemic kidney
within the same animal; this has the effect of eliminating
variability introduced by changes in the systemic acid base
balance (Table 4). Therefore, the rise in cortical cell pH at 45
mm of reflow is suggestive of and consistent with a developing
cellular alkalosis as reflected by pH dependent metabolic reac-
tions, glutamine synthesis, and conversion of membrane—bound
gamma glutamyltransferase to its soluble form [20]. Note that a
cellular alkalosis reportedly develops following transient ische-
mia in other tissues [21]. The reparative significance of these
remarkable swings in cellular acid—base homeostasis in the
recovery from ischemia, if any, remains to be determined.
Cellular acid—base homeostasis in the post-ischemic state
could reflect hydrogen ion extrusion into the extracellular fluid
and/or metabolic consumption of hydrogen ions. Given the
asymmetrical distribution of the H /Na exchange site on the
luminal brush border membrane [22, 23], extrusion of acid
might be expected to result in acidification of the glomerular
filtrate. However, urinary acidification did not occur in the
post-ischemic kidney, despite a Q-02 which exceeds the control
value (Table 4). The absence of titratable acid and the reduction
of ammonium excretion as well as net bicarbonate release raises
the possibility that there may be an important role for a
nonexcretory renal metabolic mechanism for cellular acid base
homeostasis [6]. According to this mechanism the utilization of
certain substrates results in products which could consume
acid. As an example, the sodium salt of citric acid can be
converted to the neutral product glucose generating NaHCO3
[6]. In the post-ischemic recovery period, the metabolism of
sodium salts of, for example, lactic and citric acid, could
generate bicarbonate by this mechanism; consistent with this is
the reported rapid decline in the accumulated lactate upon
reflow [18, 19] as well as renal venous HCO3 release (Table 1).
Further generation of HCO3 requires uptake and metabolic
conversion of exogenous base generating substrates; unfortu-
nately, no information is available on the metabolic fuel mix
utilized in the post-ischemic recovery period.
Renal glutamine uptake and ammonia production are respon-
sive to systemic metabolic acidosis [25]. In acute metabolic
acidosis, cortical cell pH measured by the DM0 method falls
from 6.99 0.02 in control to 6.83 0.02 [3] associated with
alterations in renal glutamine metabolism [5]. Net bicarbonate
generation follows if glutamine's carbon skeleton, alpha
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ketoglutaric acid, is converted to neutral products and the
amide and amino nitrogen atoms are excreted as ammonium [41.
In the present study, renal cell pH fell far below that seen in
metabolic acidosis, and then rose. Renal ammonia production
was maintained initially, 0 to 15 mm of reflow, and then fell at
15 to 30 mm of reflow to an actual reversal of uptake at 30 to 45
mm. Glutamine utilization reflected this pattern as an initial
small uptake reverted to release at 45 mm; cellular alkalosis at
45 mm of reflow was associated with ammonia uptake and
release of glutamine. Note that glutamine synthetase activity is
localized in the proximal straight segment of the nephron [261,
and its activity increases in alkalosis [27]. Therefore, the net
glutamine synthesis which occurred at this time was consistent
with the observed cellular alkalosis. On the nephron level, the
proximal straight segment was most sensitive to ischemia [28],
which may in part be a reflection of the augmented Q-02 and
biosynthetic activity (glutamine synthesis) observed at this
time; this in turn may develop the latent ischemia—induced
damage occurring at this sensitive nephron site [29].
Ammonia production underwent a striking increase during
the final 15 mm reflow period at 45 to 60 mm. Ammoniagenesis
at this time actually exceeded the control when factored by
GFR, despite the alkaline pH and preceeding period of cellular
alkalosis. Furthermore, ammoniagenesis during the control
period was not supported by glutamine uptake, while that
occurring at 45 to 60 mm was associated with a large extraction.
In fact, over the time period of 45 to 60 minutes, renal ammonia
uptake and glutamine release reversed to a large glutamine
extraction and ammonia production, not unlike that observed in
other forms of acute renal failure [28]. Interestingly, this
glutamine utilization did not support base generation and far
exceeded the ammonia released; indicating that only one mole
of ammonia was released per glutamine extracted. A recently
reported in vitro study of glutamine utilization by kidney slices
from rats under going acute renal failure suggested enhanced
glutamine utilization may be coupled to processes such as
nucleotide synthesis [29], essential for post-ischemic cellular
reparation [30].
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